• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23537 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2006     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) State of Knowledge on the The VestTM (from Hill-Rom), a mechanical system for mucociliary clearance of the airway
2006     West Midlands Health Technology Assessment Collaboration (WMHTAC) Simple interventions to prevent respiratory and gastrointestinal infection in children in day care and school settings - a systematic review and economic evaluation
2006     Agency for Healthcare Research and Quality (AHRQ) B vitamins and berries and age-related neurodegenerative disorders
2006     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) State of Knowledge on the eFlow rapid (from PARI), an electronic nebuliser
2006     Agency for Healthcare Research and Quality (AHRQ) Management of eating disorders
2006     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Impact assessment of the TV3 Telethon on biomedical research in Catalonia
2006     Norwegian Knowledge Centre for the Health Services (NOKC) Patient isolation for the control of airborne infections in hospitals
2006     HAYES, Inc. Continuous subcutaneous terbutaline infusion for treatment of preterm labor
2006     Norwegian Knowledge Centre for the Health Services (NOKC) The health effects of replacing amalgam fillings
2006     HAYES, Inc. CoughAssist Mechanical Insufflation-Exsufflation (MI-E) Device (J. H. Emerson Co.) for respiratory insufficiency
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Aromatase inhibitors (anastrozole, letrozole and examestane) for adjuvant therapy in early breast cancer
2006     Norwegian Knowledge Centre for the Health Services (NOKC) TNF-inhibitors in rheumatoid diseases
2006     HAYES, Inc. Renal stenting for treatment of renal stenosis in patients with hypertension
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Bisphosphonates as treatment for breast cancer]
2006     Norwegian Knowledge Centre for the Health Services (NOKC) Age determination in minor asylum seekers
2006     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Visual mobility aids for patients with night blindness]
2006     Norwegian Knowledge Centre for the Health Services (NOKC) Radiofrequency ablation in treatment of atrial fibrillation
2006     HAYES, Inc. Robotically assisted adrenalectomy (da Vinci Surgical System) (Intuitive Surgical Inc.)
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Cetuximah given in combination for patients with colorectal cancer]
2006     Blue Cross Blue Shield Association (BCBS) External counterpulsation for treatment of chronic stable angina pectoris and chronic heart failure
2006     New Zealand Health Technology Assessment (NZHTA) GP post-entry clinical training. Part 2: GP vocational training. A systematic overview of the literature
2006     HAYES, Inc. Deep brain stimulation for treatment of movement disorders of multiple sclerosis
2006     Blue Cross Blue Shield Association (BCBS) Special report: intensity-modulated radiation therapy for cancer of the breast or lung
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Device for Intervertebral Assisted Motion (DIAM) in spine instability
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Transcutaneous electrical nerve stimulation (TENS-PENS) for back pain
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Vagus Nerve Stimulation for refractory epilepsy
2006     HAYES, Inc. Digital infrared imaging (thermography) for detection of breast cancer
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of synthetic graft in knee anterior cruciate ligament reconstruction
2006     VA Technology Assessment Program (VATAP) Appropriate use of insulin pump-real-time continuous glucose monitoring systems in the veteran population
2006     Agency for Healthcare Research and Quality (AHRQ) Measuring quality of life for patients with age-related macular degeneration
2006     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of agalsidase beta (Fabrazyme®) within NHS Wales
2006     Agency for Healthcare Research and Quality (AHRQ) Non-invasive imaging for coronary artery disease
2006     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of adalimumab (Humira®) within NHS Wales
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Outpatient BiPAP (bi-level positive airway pressure) in obstructive sleep apnea
2006     Agency for Healthcare Research and Quality (AHRQ) Horizon scan on hip replacement surgery
2006     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of cetuximab (Erbitux®) within NHS Wales
2006     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) The opinion of practitioners and internists on the impact of new health technologies
2006     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of mycophenolic acid as a sodium salt (Myfortic®) within NHS Wales
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Technology assessment of wound care with SEPS]
2006     HAYES, Inc. Serum carcinoembryonic antigen (CEA) assay for diagnosis of ovarian cancer
2006     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of liposomal cytarabine (DepoCyte®) within NHS Wales
2006     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [R-COD Browser - Web-based software to determine the mortality in Germany from all causes of death according to ICD-10 within the period 1998-2003]
2006     Agency for Healthcare Research and Quality (AHRQ) Criteria for distinguishing effectiveness from efficacy trials in systematic reviews
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Trastuzumab as adjuvant treatment of early breast cancer after surgical treatment]
2006     Adelaide Health Technology Assessment (AHTA) Genetic testing for Long QT syndrome to identify individuals at high-risk of sudden cardiac death
2006     Basque Office for Health Technology Assessment (OSTEBA) [Assessment of the effectiveness of the intraoperative detection of the sentry ganglion in solid tumours]
2006     Adelaide Health Technology Assessment (AHTA) USCOM cardiac output monitor for patients requiring haemodynamic monitoring
2006     Medical Advisory Secretariat (MAS) Hydrophilic catheters: an evidence-based analysis
2006     Quality Improvement Scotland (NHS QIS ) Parent-training/education programmes in the management of children with conduct disorders
2006     HAYES, Inc. Epidural adhesiolysis for chronic back pain
2006     Adelaide Health Technology Assessment (AHTA) NMP22 BladderChek™ for the detection of bladder cancer
2006     Agency for Healthcare Research and Quality (AHRQ) Value of the periodic health evaluation
2006     Medical Advisory Secretariat (MAS) Metal-on-metal total hip resurfacing arthroplasty: an evidence-based analysis
2006     Quality Improvement Scotland (NHS QIS ) Etanercept and efalizumab for the treatment of adults with psoriasis
2006     Adelaide Health Technology Assessment (AHTA) DXL Calscan Bone Densiometer for the measurement of bone mineral density of the os calcis
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hydroxyethyl starch (HES) as plasma expander
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis
2006     Quality Improvement Scotland (NHS QIS ) Etanercept and infliximab for the treatment of adults with psoriatic arthritis
2006     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) OP-1 Putty for posterolateral lumbar fusion
2006     Adelaide Health Technology Assessment (AHTA) Epidermal growth factor receptor mutational assay for patients with non small-cell lung carcinoma
2006     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Telehealth: clinical guidelines and technological standards for telerehabilitation]
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Rituximab for rheumatoid arthritis
2006     Quality Improvement Scotland (NHS QIS ) Laparoscopic surgery for colorectal cancer
2006     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Enterra Therapy Gastric Electrical Stimulation (GES) System for the treatment of the symptoms of medically refractory gastroparesis
2006     Adelaide Health Technology Assessment (AHTA) Implantable Collamer lens for the correction of myopic vision
2005     Agency for Healthcare Research and Quality (AHRQ) Effects of omega-3 fatty acids on cancer
2005     Alberta Heritage Foundation for Medical Research (AHFMR) Review of Health Technology Assessment products 2003 - 2004
2005     Medical Advisory Secretariat (MAS) Endovascular repair of descending thoracic aortic aneurysm: an evidence-based analysis
2005     Agency for Healthcare Research and Quality (AHRQ) Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases
2005     Alberta Heritage Foundation for Medical Research (AHFMR) Celecoxib for the treatment of pain in osteoarthritis and rheumatoid arthritis
2005     Haute Autorite de sante (HAS) Cost of quality and non-quality in care provided by healthcare organisations: current situation and proposals
2005     Adelaide Health Technology Assessment (AHTA) Clinical practice guidelines on the treatment of acute stress disorder and posttraumatic stress disorder
2005     Agency for Healthcare Research and Quality (AHRQ) Effects of omega-3 fatty acids on organ transplantation
2005     Alberta Heritage Foundation for Medical Research (AHFMR) Cost estimation of point of care b-type natriuretic peptide for the diagnosis of heart failure in the emergency department:application to Alberta
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Lung volume reduction surgery for emphysema: systematic review of studies comparing different procedures
2005     Finnish Office for Health Care Technology Assessment (Finohta) [Blood glucose self-monitoring in diabetes management]
2005     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Assessment of a waiting list patient prioritisation system for cataract and hip/knee arthroplasty surgery: summary of the main results
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Identification of preventive health care for children and young people]
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Memantine for treatment of moderate to severe Alzheimer's disease
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Intragastric balloons: a temporary treatment for obesity
2005     NIHR Health Technology Assessment programme The clinical effectiveness and cost effectiveness of immuno-suppressive regimens for renal transplantation
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Chronic periodontitis - prevention, diagnosis and treatment]
2005     New Zealand Health Technology Assessment (NZHTA) SonoPrep ultrasonic skin permeation system
2005     NIHR Health Technology Assessment programme Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis
2005     NIHR Health Technology Assessment programme The causes and effects of socio-demographic exclusions from clinical trials
2005     West Midlands Health Technology Assessment Collaboration (WMHTAC) The effectiveness and cost effectiveness of immunoglobulin replacement therapy for primary immunodeficiency and chronic lymphocytic leukaemia: a systematic review and economic evaluation
2005     West Midlands Health Technology Assessment Collaboration (WMHTAC) Probiotics for the prevention of antibiotics associated diarrhea: a systematic review
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Should one or two embryos be transferred in IVF]
2005     Medical Advisory Secretariat (MAS) Total knee replacement: an evidence-based analysis
2005     University HealthSystem Consortium (UHC) Absorbable hemostatic agents
2005     Quality Improvement Scotland (NHS QIS ) Continuous glucose monitoring in the management of diabetes mellitus
2005     Medical Advisory Secretariat (MAS) Physiotherapy rehabilitation after total knee or hip replacement: an evidence-based analysis
2005     University HealthSystem Consortium (UHC) Alvimopan
2005     Institute of Health Economics (IHE) Protocols for stillbirth investigation
2005     Quality Improvement Scotland (NHS QIS ) Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
2005     Alberta Heritage Foundation for Medical Research (AHFMR) Bridging the gap: the use of research evidence in policy development
2005     University HealthSystem Consortium (UHC) Drotrecogin update
2005     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) AcBUS standards: Assessment of FSH and LH tests in women aged 45 years and more (AcBUS = healthcare best practice agreements)
2005     Quality Improvement Scotland (NHS QIS ) Dual chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block
2005     NIHR Health Technology Assessment programme A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study